Antimicrobial efficacy of three different intracanal Endodontic medications.
- Conditions
- Health Condition 1: K029- Dental caries, unspecified
- Registration Number
- CTRI/2024/05/068117
- Lead Sponsor
- Dr Bhandary Vidula Vijay
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Systemically healthy patients (Category: American Society of Anaesthesiologists
class 1) (ASA House of Delegates 2014)31 between age group of 18-60 years with
maxillary or mandibular single rooted necrotic teeth with radiographic and clinical
evidence of asymptomatic apical periodontitis will be included in the study.
2. Teeth with necrotic pulps confirmed clinically by pulp sensitivity tests will be included.
3. Patients having no previous history of endodontic treatment will be included.
4. Patients having periapical lesions with a periapical index score of 2 and above (Ørstavik et al. 1986) will be included
5. A written informed consent will be taken from all the patients and only those patients ready to sign the consent form will be included in the study
1. Medically compromised patients will be excluded.
2. Patients who have received NSAIDs or antibiotic treatment in the three months before
the study will be excluded.
3. Teeth with completely obliterated canals will be excluded.
4. Teeth with evidence of sinus tracts, pus discharge and weeping canals will be excluded.
5. Cases showing periodontal pocket depth deeper than 4mm will be excluded.
6. Teeth with open apex, root resorption or complex root canal anatomy will be excluded.
7. Teeth with developmental anomalies will be excluded.
8. Teeth with vertical root fractures, cracks will be excluded.
9. Pregnant and lactating women will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method